Search Results - "Kariv, Rami"

A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme by Tam, Andrew, Garcia-Arieta, Alfredo, Abalos, Ivana, Agostinho Freitas Fernandes, Eduardo, Mendes Lima Santos, Gustavo, Rodriguez Martinez, Zulema, Divinsky, Milly, Kariv, Rami, Potthast, Henrike, Braddy, April C, Rodrigues, Clare, Guzman Aurela, Erwin, Carolina Arevalo Gonzalez, Liliana, Gutierres Triana, Diego, Jones, Ben, Ahn, Choongyul, Kim, Hyuna, Kim, So Hee, Kuribayashi, Ryosuke, Myoenzono, Aya, Shimojo, Kohei, Van Oudtshoorn, Joy, Bigler, Cornelia, Meincke, Ricarda, Roost, Matthias S, Walther, Chantal, Hsu, Li-Feng, Crane, Christopher, Jarman, Tony

“…The safety and efficacy of a generic product are partly based on demonstrating bioequivalence to the innovator product; however, when the innovator product is…”
Get full text

Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities by Roost, Matthias Shona, Potthast, Henrike, Walther, Chantal, García-Arieta, Alfredo, Abalos, Ivana, Agostinho Freitas Fernandes, Eduardo, Mendes Lima Santos, Gustavo, Rodríguez Martínez, Zulema, Tam, Andrew, Rodrigues, Clare, Gutierrez Triana, Diego Alejandro, Guzmán Aurela, Erwin, Rodríguez Rodríguez, Nayive, Aeh Park, Sang, Kim, Jayoung, Kariv, Rami, Divinsky, Milly, Jones, Ben, Kuribayashi, Ryosuke, Myoenzono, Aya, Kasuga, Miho, Van Oudtshoorn, Joy, Chi, Jo-Feng, Hung, Wen-Yi, Hsu, Li-Feng, Crane, Christopher, Jarman, Tony, Braddy, April

“…This article describes an overview of waivers of in vivo bioequivalence studies for additional strengths in the context of the registration of modified release…”
Get full text

Simulation of the hepatic metabolism of stilbene and its tricyclic derivatives by Fenton and Ruff reagents: models for cytochrome P-450 activation of chemical carcinogens by Zbaida, S, Kariv, R

“…Reactions of trans-stilbene, cis-stilbene, 5H-dibenzo [a,d] cyclo-heptene 5-one and 5H-dibenz [b,f] azepine (iminostilbene) with Fenton reagent [Fe (II)/H2O2]…”
Get more information

The role of iron chelates on the selectivity of Fenton reagent in hydroxylation, N-demethylation, and sulfoxidation of cimetidine: a novel biomimetic model for the regioselectivity of cytochrome P-450 by Zbaida, S, Kariv, R, Fischer, P

“…The effect of iron chelates on the reaction of cimetidine with Fenton reagent [Fe(II)/H2O2] has been investigated. Iron chelates with high affinity to ferrous…”
Get more information

Biomimetic models for monooxygenases by Zbaida, S, Kariv, R

“…The microsomal mixed function oxidase system contains the cytochrome P-450 oxidative drug metabolizing family of enzymes. The catalytic cycle of cytochrome…”
Get more information

Reaction of cimetidine with Fenton reagent by ZBAIDA, Shmuel, KARIV, Rami, FISCHER, Paula, SILMAN‐GREENSPAN, Judith, TASHMA, Zeev

“…Cimetidine sulfoxide, N‐desmethylcimetidine, N‐desmethylcimetidine sulfoxide, cimetidine guanylurea, and the 5‐hydroxymethylimidazole derivative of cimetidine…”
Get full text

Reaction of cimetidine with Fenton reagent: a biomimetic model for the mixed-function oxidase drug metabolism by ZBAIDA, S, KARIV, R, FISCHER, P, SILMAN-GREENSPAN, J, TASHMA, Z

“…Cimetidine sulfoxide, N-desmethylcimetidine, N-desmethylcimetidine sulfoxide, cimetidine guanylurea, and the 5-hydroxymethylimidazole derivative of cimetidine…”
Get full text